Tekla Capital Management LLC Bristol Myers Squibb CO Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tekla Capital Management LLC holds 458,498 shares of BMY stock, worth $23.3 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

458,498

Previous 663,796 30.93%

Holding current value

$23.3 Million

Previous $46 Million 36.27%

% of portfolio

1.16%

Previous 1.77%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $13.1 Million - $14.5 Million	-205,298 Reduced 30.93%	458,498 $29.3 Million
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $1.56 Million - $1.77 Million	-23,733 Reduced 3.45%	663,796 $46 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $13.1 Million - $15.6 Million	-191,947 Reduced 21.83%	687,529 $49.5 Million
Q3 2022 Nov 01, 2022	BUY	$0.13 - $76.84 $12,576 - $7.43 Million	96,741 Added 12.36%	879,476 $62.5 Million
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $4.27 Million - $4.71 Million	58,859 Added 8.13%	782,735 $60.3 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $1.42 Million - $1.71 Million	-23,167 Reduced 3.1%	723,876 $52.9 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $7.23 Million - $8.43 Million	134,807 Added 22.02%	747,043 $46.6 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $2.59 Million - $3.03 Million	-43,737 Reduced 6.67%	612,236 $36.2 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $14.6 Million - $15.9 Million	-236,480 Reduced 26.5%	655,973 $43.8 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $5.78 Million - $6.5 Million	-97,455 Reduced 9.84%	892,453 $56.3 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $2.58 Million - $2.93 Million	44,768 Added 4.74%	989,908 $61.4 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $1.86 Million - $2.06 Million	-32,365 Reduced 3.31%	945,140 $57 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $7.27 Million - $8.5 Million	132,573 Added 15.69%	977,505 $57.5 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $3.25 Million - $4.72 Million	70,070 Added 9.04%	844,932 $47.1 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $1.81 Million - $2.36 Million	36,818 Added 4.99%	774,862 $49.7 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $3.84 Million - $4.58 Million	85,078 Added 13.03%	738,044 $35.2 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $14 Million - $18.1 Million	286,902 Added 78.37%	652,966 $33.9 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $15.7 Million - $17.7 Million	-284,966 Reduced 43.77%	366,064 $22.7 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $6.33 Million - $7.89 Million	125,308 Added 23.84%	651,030 $36 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $10.6 Million - $12.2 Million	176,601 Added 50.58%	525,722 $33.3 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $20.9 Million - $22.8 Million	349,121 New	349,121 $21.4 Million
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $10.3 Million - $11.9 Million	-186,500 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	186,500	186,500 $10.4 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Bristol Myers Squibb CO Transaction History